Quantitative multiplex quantum dot in-situ hybridisation based gene expression profiling in tissue microarrays identifies prognostic genes in acute myeloid leukaemia

Biochemical and Biophysical Research Communications

Volumn 425, Issue 2, 2012, Pages 333-339

  Tholouli, Eleni ^a   MacDermott, Sarah ^b,d   Hoyland, Judith ^c   Yin, John Liu ^a   Byers, Richard ^c  

^a MANCHESTER ROYAL INFIRMARY   (United Kingdom)

^b UNIVERSITY OF MANCHESTER   (United Kingdom)

^c UNIVERSITY OF MANCHESTER   (United Kingdom)

^d UNIVERSITY OF LEEDS   (United Kingdom)

Author keywords

Acute myeloid leukaemia; Gene expression; Prognosis; Quantum dots; Spectral imaging; Tissue microarrays

Indexed keywords

DNA METHYLTRANSFERASE 3A; DNA METHYLTRANSFERASE 3B; OLIGONUCLEOTIDE; QUANTUM DOT; TRANSCRIPTION FACTOR HOXA9;

ACUTE GRANULOCYTIC LEUKEMIA; ADOLESCENT; ADULT; ARTICLE; BONE MARROW BIOPSY; CANCER SURVIVAL; FEMALE; GENE EXPRESSION PROFILING; GENETIC ANALYSIS; HUMAN; HUMAN TISSUE; IMAGE ANALYSIS; IN SITU HYBRIDIZATION; LEUKOCYTE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; QUANTITATIVE STUDY; TISSUE MICROARRAY; TREATMENT FAILURE;

ADULT; AGED; FEMALE; GENE EXPRESSION PROFILING; HOMEODOMAIN PROTEINS; HUMANS; IN SITU HYBRIDIZATION; LEUKEMIA, MYELOID, ACUTE; MALE; MIDDLE AGED; NEOPLASM PROTEINS; PROGNOSIS; QUANTUM DOTS; SURVIVAL ANALYSIS; TISSUE ARRAY ANALYSIS; YOUNG ADULT;

EID: 84865373489     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2012.07.092     Document Type: Article

References (29)

1. Ebert B.L., Golub T.R. Genomic approaches to hematologic malignancies. Blood 2004, 104:923-932.
2. Wilcox J.N. Fundamental principles of in situ hybridization. J. Histochem. Cytochem. 1993, 41:1725-1733.
3. Kind C.N. The application of in-situ hybridisation and immuno-cytochemistry to problem resolution in drug development. Toxicol. Lett. 2000, 112-113:487-492.
4. Dirks R.W., Van Gijlswijk R.P., Vooijs M.A., Smit A.B., Bogerd J., van Minnen J., Raap A.K., Van der Ploeg M. 3'-end fluorochromized and haptenized oligonucleotides as in situ hybridization probes for multiple, simultaneous RNA detection. Exp. Cell Res. 1991, 194:310-315.
5. Dittrich P., Malvezzi-Campeggi F., Jahnz M., Schwille P. Accessing molecular dynamics in cells by fluorescence correlation spectroscopy. Biol. Chem. 2001, 382:491-494.
6. Banerjee B., Miedema B., Chandrasekhar H.R. Emission spectra of colonic tissue and endogenous fluorophores. Am. J. Med. Sci. 1998, 316:220-226.
7. Del Castillo P., Llorente A.R., Stockert J.C. Influence of fixation, exciting light and section thickness on the primary fluorescence of samples for microfluorometric analysis. Basic Appl. Histochem. 1989, 33:251-257.
8. Byers R.J., Di Vizio D., O'Connell F., Tholouli E., Levenson R.M., Gossage K., Twomey D., Yang Y., Benedettini E., Rose J., Ligon K.L., Finn S.P., Golub T.R., Loda M. Semiautomated multiplexed quantum dot-based in situ hybridization and spectral deconvolution. J. Mol. Diagn. 2007, 9:20-29.
9. Tholouli E., Hoyland J.A., Di Vizio D., O'Connell F., Macdermott S.A., Twomey D., Levenson R., Yin J.A., Golub T.R., Loda M., Byers R. Imaging of multiple mRNA targets using quantum dot based in situ hybridization and spectral deconvolution in clinical biopsies. Biochem. Biophys. Res. Commun. 2006, 348:628-636.
10. Jubb S., Landon T.H., Burwick J., Pham T.Q., Frantz G.D., Cairns B., Quirke P., Peale F.V., Hillan K.J. Quantitative analysis of colorectal tissue microarrays by immunofluorescence and in situ hybridization. J. Pathol. 2003, 200:577-588.
11. Farkas D.L., Du C., Fisher G.W., Lau C., Niu W., Wachman E.S., Levenson R.M. Non-invasive image acquisition and advanced processing in optical bioimaging. Comput. Med. Imaging Graph 1998, 22:89-102.
12. Bullinger L., Dohner K., Bair E., Frohling S., Schlenk R.F., Tibshirani R., Dohner H., Pollack J.R. Use of gene-expression profiling to identify prognostic subclasses in adult acute myeloid leukemia. N. Engl. J. Med. 2004, 350:1605-1616.
13. Bullinger L., Rucker F.G., Kurz S., Du J., Scholl C., Sander S., Corbacioglu A., Lottaz C., Krauter J., Frohling S., Ganser A., Schlenk R.F., Dohner K., Pollack J.R., Dohner H. Gene-expression profiling identifies distinct subclasses of core binding factor acute myeloid leukemia. Blood 2007, 110:1291-1300.
14. P.J. Valk, R.G. Verhaak, M.A. Beijen, C.A. Erpelinck, S. Barjesteh van Waalwijk van Doorn-Khosrovani, J.M. Boer, H.B. Beverloo, M.J. Moorhouse, P.J. van der Spek, B. Lowenberg, and R. Delwel, Prognostically useful gene-expression profiles in acute myeloid leukemia. N. Engl. J. Med. 350 (2004) 1617-28.
15. Grubach L., Juhl-Christensen C., Rethmeier A., Olesen L.H., Aggerholm A., Hokland P., Ostergaard M. Gene expression profiling of Polycomb, Hox and Meis genes in patients with acute myeloid leukaemia. Eur. J. Haematol. 2008, 81:112-122.
16. Golub T.R., Slonim D.K., Tamayo P., Huard C., Gaasenbeek M., Mesirov J.P., Coller H., Loh M.L., Downing J.R., Caligiuri M.A., Bloomfield C.D., Lander E.S. Molecular classification of cancer: class discovery and class prediction by gene expression monitoring. Science 1999, 286:531-537.
17. Drabkin H.A., Parsy C., Ferguson K., Guilhot F., Lacotte L., Roy L., Zeng C., Baron A., Hunger S.P., Varella-Garcia M., Gemmill R., Brizard F., Brizard A., Roche J. Quantitative HOX expression in chromosomally defined subsets of acute myelogenous leukemia. Leukemia 2002, 16:186-195.
18. Kroon E., Krosl J., Thorsteinsdottir U., Baban S., Buchberg A.M., Sauvageau G. Hoxa9 transforms primary bone marrow cells through specific collaboration with Meis1a but not Pbx1b. Embo J. 1998, 17:3714-3725.
19. Wilson C.S., Davidson G.S., Martin S.B., Andries E., Potter J., Harvey R., Ar K., Xu Y., Kopecky K.J., Ankerst D.P., Gundacker H., Slovak M.L., Mosquera-Caro M., Chen I.M., Stirewalt D.L., Murphy M., Schultz F.A., Kang H., Wang X., Radich J.P., Appelbaum F.R., Atlas S.R., Godwin J., Willman C.L. Gene expression profiling of adult acute myeloid leukemia identifies novel biologic clusters for risk classification and outcome prediction. Blood 2006, 108:685-696.
20. Thorsteinsdottir U., Kroon E., Jerome L., Blasi F., Sauvageau G. Defining roles for HOX and MEIS1 genes in induction of acute myeloid leukemia. Mol. Cell Biol. 2001, 21:224-234.
21. Thorsteinsdottir U., Mamo A., Kroon E., Jerome L., Bijl J., Lawrence H.J., Humphries K., Sauvageau G. Overexpression of the myeloid leukemia-associated Hoxa9 gene in bone marrow cells induces stem cell expansion. Blood 2002, 99:121-129.
22. Calvo K.R., Sykes D.B., Pasillas M.P., Kamps M.P. Nup98-HoxA9 immortalizes myeloid progenitors, enforces expression of Hoxa9, Hoxa7 and Meis1, and alters cytokine-specific responses in a manner similar to that induced by retroviral co-expression of Hoxa9 and Meis1. Oncogene 2002, 21:4247-4256.
23. Calvo K.R., Knoepfler P.S., Sykes D.B., Pasillas M.P., Kamps M.P. Meis1a suppresses differentiation by G-CSF and promotes proliferation by SCF: potential mechanisms of cooperativity with Hoxa9 in myeloid leukemia. Proc. Natl. Acad. Sci. USA 2001, 98:13120-13125.
24. Deveraux Q.L., Roy N., Stennicke H.R., Van Arsdale T., Zhou Q., Srinivasula S.M., Alnemri E.S., Salvesen G.S., Reed J.C. IAPs block apoptotic events induced by caspase-8 and cytochrome c by direct inhibition of distinct caspases. Embo J. 1998, 17:2215-2223.
25. Wermuth P.J., Buchberg A.M. Meis1-mediated apoptosis is caspase dependent and can be suppressed by coexpression of HoxA9 in murine and human cell lines. Blood 2005, 105:1222-1230.
26. Robertson K.D., Uzvolgyi E., Liang G., Talmadge C., Sumegi J., Gonzales F.A., Jones P.A. The human DNA methyltransferases (DNMTs) 1, 3a and 3b: coordinate mRNA expression in normal tissues and overexpression in tumors. Nucleic Acids Res. 1999, 27:2291-2298.
27. Mizuno S., Chijiwa T., Okamura T., Akashi K., Fukumaki Y., Niho Y., Sasaki H. Expression of DNA methyltransferases DNMT1, 3A, and 3B in normal hematopoiesis and in acute and chronic myelogenous leukemia. Blood 2001, 97:1172-1179.
28. Esteve P.O., Chin H.G., Pradhan S. Human maintenance DNA (cytosine-5)-methyltransferase and p53 modulate expression of p53-repressed promoters. Proc. Natl. Acad. Sci. USA 2005, 102:1000-1005.
29. Ley T.J., Ding L., Walter M.J., McLellan M.D., Lamprecht T., Larson D.E., Kandoth C., Payton J.E., Baty J., Welch J., Harris C.C., Lichti C.F., Townsend R.R., Fulton R.S., Dooling D.J., Koboldt D.C., Schmidt H., Zhang Q., Osborne J.R., Lin L., O'Laughlin M., McMichael J.F., Delehaunty K.D., McGrath S.D., Fulton L.A., Magrini V.J., Vickery T.L., Hundal J., Cook L.L., Conyers J.J., Swift G.W., Reed J.P., Alldredge P.A., Wylie T., Walker J., Kalicki J., Watson M.A., Heath S., Shannon W.D., Varghese N., Nagarajan R., Westervelt P., Tomasson M.H., Link D.C., Graubert T.A., Dipersio J.F., Mardis E.R., Wilson R.K. DNMT3A Mutations in Acute Myeloid Leukemia. N. Engl. J. Med. 2010, 363:2424-2433.